ArticleAmerican journal of translational research2025
Early risk identification for recurrent wheezing in children with respiratory syncytial virus infections.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the predictive value of peripheral blood eosinophil (EOS) count and nasopharyngeal microbiota for recurrent wheezing in children following respiratory syncytial virus (RSV) lower respiratory tract infections.
methodsThis retrospective study included 614 children with RSV infection and an external validation cohort of 164 children. Clinical data, hematological parameters, and nasopharyngeal microbiota profiles were collected. Logistic regression was used to identify independent predictors of recurrent wheezing. A predictive model was developed and validated using receiver operating characteristic (ROC) and calibration curves.
resultsPeripheral blood EOS count, serum 25(OH)D and IgM levels, and nasopharyngeal bacterial colonization (notably
conclusionPeripheral blood EOS count and nasopharyngeal microbiota composition are critical predictors of recurrent wheezing following RSV infection. The predictive model may aid in early risk stratification and personalized intervention to prevent recurrent wheezing in pediatric patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.